Table 3.
HIV-infected patients (n = 73) |
Control subjects (n = 21) |
|||||||
---|---|---|---|---|---|---|---|---|
Marker | CCA IMTa | P | ICA IMTa | P | CCA IMTa | P | ICA IMTa | P |
Age | 0.54 | .001 | 0.47 | .001 | 0.66 | .001 | 0.53 | .01 |
Non-HDL cholesterol | 0.27 | .02 | 0.25 | .04 | ... | ... | ||
Triglycerides | 0.25 | .03 | ... | 0.6 | .004 | ... | ||
HOMA-IR score | 0.24 | .04 | ... | ... | 0.44 | .05 | ||
hsCRP | ... | 0.26 | .03 | 0.47 | .03 | ... | ||
sVCAM-1 | ... | ... | ... | –0.70 | <.001 |
NOTE. No significant correlations were found between IMT and biomarkers not listed in the table (ie, TNF-α, sTNFR-I, sTNFR-II, IL-6, MPO, sICAM-1, and vWF), as well as between IMT and TC, HDL, LDL, or BMI. BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters); CCA, common carotid artery; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; ICA, internal carotid artery; IL, interleukin; IMT, intima-media thickness; LDL, low-density lipoprotein; MPO, myeloperoxidase; sICAM-1, soluble intercellular adhesion molecule-1; sTNFR-I, soluble tumor necrosis factor-α receptor I; sTNFR-II, soluble tumor necrosis factor-α receptor II; sVCAM-1, soluble vascular cell adhesion molecule-1; TC, total cholesterol; TNF-α, tumor necrosis factor-α; vWF, von Willebrand factor.
Spearman correlation coefficient (ρ).